Order Article Reprints

van Ravensteijn SG, Versleijen-Jonkers YMH, Hillebrandt-Roeffen MHS, Weidema ME, Nederkoorn MJL, Bol KF, Gorris MAJ, Verrijp K, Kroeze LI, de Bitter TJJ, et al. Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups. Cancers. 2022; 14(23):5938. https://doi.org/10.3390/cancers14235938

van Ravensteijn, Stefan G., Yvonne M. H. Versleijen-Jonkers, Melissa H. S. Hillebrandt-Roeffen, Marije E. Weidema, Maikel J. L. Nederkoorn, Kalijn F. Bol, Mark A. J. Gorris, Kiek Verrijp, Leonie I. Kroeze, Tessa J. J. de Bitter, and et al. 2022. "Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups" Cancers 14, no. 23: 5938. https://doi.org/10.3390/cancers14235938

van Ravensteijn, S. G., Versleijen-Jonkers, Y. M. H., Hillebrandt-Roeffen, M. H. S., Weidema, M. E., Nederkoorn, M. J. L., Bol, K. F., Gorris, M. A. J., Verrijp, K., Kroeze, L. I., de Bitter, T. J. J., de Voer, R. M., Flucke, U. E., & Desar, I. M. E. (2022). Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups. Cancers, 14(23), 5938. https://doi.org/10.3390/cancers14235938